181,747 Koninklijke Philips N.V. $PHG Shares Sold by Mondrian Investment Partners LTD

Mondrian Investment Partners LTD lowered its holdings in Koninklijke Philips N.V. (NYSE:PHG) by 2.3% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 7,885,781 shares of the technology company’s stock after selling 181,747 shares during the quarter. Koninklijke Philips accounts for 4.2% of Mondrian Investment Partners LTD’s holdings, making the stock its 7th biggest position. Mondrian Investment Partners LTD’s holdings in Koninklijke Philips were worth $192,650,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in PHG. Bessemer Group Inc. raised its holdings in shares of Koninklijke Philips by 19.8% during the first quarter. Bessemer Group Inc. now owns 2,756 shares of the technology company’s stock worth $76,000 after purchasing an additional 456 shares during the last quarter. HB Wealth Management LLC lifted its position in Koninklijke Philips by 3.3% during the first quarter. HB Wealth Management LLC now owns 16,854 shares of the technology company’s stock valued at $462,000 after purchasing an additional 539 shares during the period. First Trust Advisors LP lifted its position in Koninklijke Philips by 1.1% during the first quarter. First Trust Advisors LP now owns 59,131 shares of the technology company’s stock valued at $1,620,000 after purchasing an additional 625 shares during the period. Trust Point Inc. boosted its holdings in Koninklijke Philips by 10.3% in the second quarter. Trust Point Inc. now owns 9,236 shares of the technology company’s stock valued at $251,000 after purchasing an additional 864 shares during the last quarter. Finally, Cloverfields Capital Group LP boosted its holdings in Koninklijke Philips by 1.2% in the first quarter. Cloverfields Capital Group LP now owns 70,940 shares of the technology company’s stock valued at $1,944,000 after purchasing an additional 868 shares during the last quarter. Institutional investors and hedge funds own 13.67% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages have weighed in on PHG. UBS Group reaffirmed a “neutral” rating on shares of Koninklijke Philips in a research report on Monday, August 3rd. Weiss Ratings raised Koninklijke Philips from a “hold (c)” rating to a “hold (c+)” rating in a report on Wednesday. Finally, Zacks Research raised Koninklijke Philips from a “strong sell” rating to a “hold” rating in a report on Thursday, August 13th. Five research analysts have rated the stock with a Hold rating. According to MarketBeat, the stock presently has a consensus rating of “Hold”.

Koninklijke Philips Stock Performance

Shares of PHG stock opened at $26.90 on Friday. The company has a market capitalization of $26.44 billion, a P/E ratio of 19.82, a P/E/G ratio of 11.18 and a beta of 0.77. The business’s 50 day moving average is $25.54 and its two-hundred day moving average is $26.43. The company has a current ratio of 1.26, a quick ratio of 0.82 and a debt-to-equity ratio of 0.55. Koninklijke Philips N.V. has a 12-month low of $23.62 and a 12-month high of $33.44.

Koninklijke Philips (NYSE:PHG) last issued its quarterly earnings data on Monday, July 27th. The technology company reported $0.57 EPS for the quarter, beating the consensus estimate of $0.40 by $0.17. The company had revenue of $4.98 billion for the quarter, compared to analyst estimates of $4.91 billion. Koninklijke Philips had a return on equity of 14.38% and a net margin of 6.30%. Koninklijke Philips’s quarterly revenue was down 3.0% compared to the same quarter last year. During the same period last year, the company earned $0.27 earnings per share. Analysts expect that Koninklijke Philips N.V. will post 1.74 EPS for the current fiscal year.

Koninklijke Philips Profile

Koninklijke Philips N.V. is a Netherlands-based health technology company that develops products, services and software for healthcare providers, patients and consumers. Its portfolio includes diagnostic imaging systems, such as magnetic resonance imaging, computed tomography and X-ray equipment; ultrasound systems; image-guided therapy technologies; patient monitoring and hospital informatics solutions; and connected care products.

Philips also serves consumers through personal health products, including electric toothbrushes, oral healthcare systems, mother and child care products, and sleep and respiratory care devices.